February 24, 2025 Bulletins MENTAL HEALTH AND SUBSTANCE USE DISORDER PARITY DATA CALL, CONFIDENTIALITY OF DATA SUBMISSIONS UPDATED BULLETIN 2024-021 UPDATE: The data submitted pursuant to the data call described in the bulletin will be deemed confidential pursuant to NMSA 1978, Sections 59A-2-12(B), 59A-18-13.2(G), 59A-23-30, 59A-46-69, and 59A-47-64. The Mental Health Parity and Addiction Equity Act (MHPAEA), amended in November 2013, includes provisions that require group health plans and health insurance carriers to ensure Mental Health and Substance Use Disorder (MH/SUD) parity with Medical and Surgical (Med/Surg) services. This includes performing and documenting comparative analyses of network adequacy, pharmacy benefits, quantitative treatment limitations (QTLs) and nonquantitative treatment limitations (NQTLs). Group plans and health insurance carriers are further required to make these analyses available to applicable state authorities upon request. Pursuant to NMSA 1978, Section 59A-4-3, and to ensure that all New Mexicans have access to care and coverage compliant with state and federal parity requirements, the New Mexico Office of Superintendent of Insurance (OSI) directs every subject health plan to submit data and comparative analyses, using the attached data call tools. Group plans and health insurance carriers are required to report data and analyses regarding health care coverage for plan years beginning on or after January 1, 2023, and offered through December 31, 2023, i.e., Plan Year 2023. For complete content please see PDF below. MENTAL HEALTH AND SUBSTANCE USE DISORDER PARITY DATA CALL, CONFIDENTIALITY OF DATA SUBMISSIONS
June 26, 2026 Bulletins MEDICAL MALPRACTICE PREMIUM REDUCTION AMENDED BULLETIN 2026-010: The New Mexico State Legislature appropriated $5 million to the New Mexico Office of Superintendent of Insurance (OSI) to address medical malpractice insurance costs for individual providers. The appropriation was part of a supplemental appropriation package passed in 2025. This one-time appropriation directs OSI to provide a premium subsidy for private medical malpractice insurance policies. […] Read More
June 12, 2026 Announcements NOTICE OF PRESCRIPTION DRUG PRICE TRANSPARENCY ANNUAL MEETING The Office of the Superintendent of Insurance will hold its annual public meeting to present and discuss the findings and recommendations contained in the 2025 Prescription Drug Price Transparency legislative report. The purpose of this meeting is to inform the public of the report’s contents and to provide an opportunity for public comments and questions. […] Read More